Loading
Latest filing published 17 May 2023 for iSpecimen Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Christopher Ianelli in iSpecimen Inc., where the filings describe the role as chief executive. Over a trading history stretching from 21 June 2021 to 6 January 2023, the count stands at 7 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 17 May 2023 with a share grant in iSpecimen Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations